The University of New South Wales Sydney (UNSW) & National Drug and Alcohol Research Centre (NDARC) recently invited Dr. Steven Shoptaw to lecture at a collaborative seminar titled, ASCEND: Therapeutic Interventions for Methamphetamine Dependence. Methamphetamine dependence is a growing public health concern in Australia and many parts of the world. There are currently no approved pharmacotherapies for its treatment, but researchers have been evaluating potentially effective medications as possible treatment options. The ASCEND program (Advancing the health or people who use drugs: hepatitis C and drug dependence) webinar presented an overview of the evidence for treatment of methamphetamine dependence and included lectures from UNSW Professor, Dr. Rebecca McKetin and UNSW Professor and director of the National Centre for Clinical Research on Emerging Drugs (NCCRED), Dr. Nadine Ezard. A recording of the webinar can be found here. To read more about NDARC, its current research, and the work being done under the ASCEND program, please visit the following: NDARC & ASCEND



CBAM is a multidisciplinary center that seeks to advance the prevention and treatment of chronic illnesses, especially in communities with health disparities. As part of the UCLA Department of Family Medicine, CBAM works at the intersection of academia and community with a focus on treating addictions and preventing the spread of HIV.

© The UCLA Center for Behavioral & Addiction Medicine (CBAM). All Rights Reserved.